The budgetary impact of alemtuzumab in multiple sclerosis in Quito, Ecuador. Payer’s perspective

INTRODUCTION: Multiple sclerosis is a neurological condition that causes disabilities and is most common in young adults. It imposes high financial costs affecting the quality of life of patients, families, and society. It is critical to measure the budgetary impact of new technologies to treat this...

Descripción completa

Detalles Bibliográficos
Autores principales: Pastor-Quirós, Luis J., Correa-Díaz, Edgar P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AboutScience 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616185/
https://www.ncbi.nlm.nih.gov/pubmed/36627868
http://dx.doi.org/10.33393/grhta.2021.2273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616185/
https://www.ncbi.nlm.nih.gov/pubmed/36627868
http://dx.doi.org/10.33393/grhta.2021.2273

Ejemplares similares